Aptadir Therapeutics raised $45M in a Seed round announced on September 29, 2026. A Milan-based biotech company developing novel treatments for difficult to treat genetic conditions.
A Milan-based biotech company developing novel treatments for difficult to treat genetic conditions.
Aptadir Therapeutics, based in Milan, Italy, announced $45M in Seed financing on September 29, 2026.
Participants include Extend, CE-Ventures, 4BIO Capital, CDP Venture Capital, XGEN Venture.
Basecamp Research combines DNA analysis and environmental monitoring in its BaseDiscovery platform.
AI medical assistants and clinical workflow software for healthcare providers.
AnaCardio is a privately held clinical stage biopharmaceutical company developing novel drugs to treat heart failure.